With anticipation building for the first clinical readouts expected later in 2024, join Hummingbird Bioscience and Dartmouth's Geisel School of…
Please join Praxis Precision Medicines for a virtual update on its PRAX-628 Program. Praxis’ management will lead the discussion and…
Details to follow.
Join us to learn how Carmell Corp (Nasdaq: CTCX) is bringing the biggest technological revolution in regenerative skin and haircare to the…
Join Perspective Therapeutics management for an in-person and virtual analyst day, featuring Richard L. Wahl, MD (Professor of Radiology, Mallinckrodt Institute of…
Join Aligos Therapeutics for a virtual KOL event featuring Stephen Harrison, MD (Visiting Professor, Radcliffe Department of Medicine, University of…
Neurelis will host a 90-minute virtual investor call to highlight updates on two of its product candidates. NRL-1004 for Acute…
Join Annexon Biosciences for an overview of Guillain-Barré Syndrome (GBS), the most common cause of acute neuromuscular paralysis, featuring GBS…

Join Oculis in-person or virtually for an R&D Day, featuring multiple ophthalmology experts who will showcase two of Oculis’ clinical…
Join TScan Therapeutics for a virtual KOL event, featuring hematologist/oncologists Ran Reshef, MD, MSc (Columbia University Irving Comprehensive Cancer Center) and Monzr M. Al Malki,…
Access the replay for more information.
Join Reviva Pharmaceuticals for a virtual key opinion leader (KOL) event, featuring Larry Ereshefsky, PharmD, BCPP, FCCP (Retired professor of Psychiatry,…
Join FibroGen for Part I of a virtual KOL investor event series featuring Andrew Ko, MD (University of California San…
Join Abivax for a virtual KOL investor event featuring Marla Dubinsky, MD (Professor of Pediatrics and Medicine, Icahn School of Medicine Mount…

Join Oryzon Genomics for a virtual KOL Event to briefly review, then discuss the topline results from the Phase IIb…
Join Vera Therapeutics for a hybrid R&D day, featuring Richard Lafayette, MD, FACP, from Stanford University Medical Center, who will join company management…